The single use downstream bioprocessing market involves various product segments including bag assemblies, tubing assemblies, sampling systems, monitoring systems, filtration assemblies, connectors and dispensors, mixing systems, purification systems and other accessories. The single use bioprocessing products are witnessing high adoption in the biopharmaceutical industry owing to their advantages such as lower risk of product cross-contamination, reduced validation requirement, ease of scale-up and aseptic operations. These solutions enable reduction in capital costs, improve process productivity and efficiency for biopharmaceutical applications. Global demand for monoclonal antibodies, vaccines and other biosimilars from emerging economies is also propelling the adoption of single use bioprocessing systems.
The Single use downstream bioprocessing Market is estimated to be valued at US$ 1.51 Bn in 2024 and is expected to exhibit a CAGR of 15% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the single use downstream bioprocessing are 3M, Agilitech, CPC (Colder Products Company), Cytiva Lifesciences, Pall Corporation and Among Others. These leading players are focusing on geographical expansion and capacity additions to cater to the growing demand. For instance, Cytiva doubled its manufacturing facility in Germany in 2021.
The single use bioprocessing solutions offer various opportunities including continuous bioprocessing, personalized medicines and cell and gene therapies. With technological advancements, these technologies are becoming more efficient and economical. Further, as the biopharmaceutical manufacturing goes downstream, single use technologies are witnessing higher adoption in areas of filtration, purification and final drug substance manufacturing.
The Single use downstream bioprocessing market is expected to witness significant expansion particularly in the emerging biologics hubs in Asia Pacific and Latin America. Factors such as availability of low-cost skilled resources, favorable government policies and rising healthcare spending are attracting biopharmaceutical investment in these regions. Key players are exploring opportunities through partnerships, joint ventures and acquisitions for business and geographic expansion.
Market Drivers
Growing biologics pipeline with increasing demand for monoclonal antibodies, vaccines and other biosimilars is a major market driver. With advancement in patient centric drug development, biologics holds promise in treatment of chronic diseases. Moreover, rising R&D investments by pharmaceutical firms and adoption of disposables to reduce costs of goods sold (COGs) are fueling the single use bioprocessing systems demand.
Market Restraints
High initial costs of single use systems and lack of established waste treatment infrastructure are key challenges. Further, the dependence on limited vendors for supply of single use products can strain the production cycles. Continued dependency on traditional stainless steel based systems in emerging regions and availability of refurbished and rebuilt equipment are also restraining the market growth. Standardization of regulations is required for seamless adoption of single use technologies.
Segment Analysis
The single use downstream bioprocessing market is segmented based on product type into filtration devices, chromatography devices, centrifugation devices, mixing systems, and bags and containers. Among these, the filtration devices sub-segment dominates the market as it captures the highest market share. This is because filtration is one of the most critical and important unit operations employed across all stages of bioprocessing from cell harvesting to final drug substance formulation.
Global Analysis
Regionally, North America holds the largest share in the single use downstream bioprocessing market owing to increased adoption of single-use technologies across bioprocessing facilities in the region. This is attributed to growing biologics manufacturing and increased focus on reducing manufacturing costs. The Asia Pacific region is projected to witness the highest growth over the forecast period due to growing establishment of new bioprocessing facilities in emerging economies like China and India. Countries in this region are also focusing on attracting biopharmaceutical companies to set up manufacturing facilities and outsourcing activities.
Get more insights on this topic: https://www.dailyprbulletin.com/the-single-use-downstream-bioprocessing-market-is-trending-to-reduce-cost-and-time-in-2024/
Author Bio:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163 )
What Are The Key Data Covered In This Single Use Downstream Bioprocessing Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Single Use Downstream Bioprocessing's growth between 2024 and 2031.
:- Accurate calculation of the size of the Single Use Downstream Bioprocessing and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Single Use Downstream Bioprocessing Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Single Use Downstream Bioprocessing vendors
FAQ’s
Q.1 What are the main factors influencing the Single Use Downstream Bioprocessing?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Single Use Downstream Bioprocessing companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Single Use Downstream Bioprocessing’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it